Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

NCT06361992 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT06361992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06361992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2022
Completion date
February 13, 2024
Enrollment
58 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, atopic dermatitis \(ad\), atopic dermatitis and related conditions, atopic dermatitis eczema